This study is testing a program called Youth Opioid Recovery Support (YORS) for young adults with opioid-use disorder (OUD). The YORS program is designed to help young people stay engaged in treatment and take their medications as prescribed. It includes things like home delivery of medications (extended release naltrexone or XR-NTX, and extended release buprenorphine or XR-BUP), involving family in treatment, and using text messages and social media to stay in touch. The study aims to enroll 150 participants. Success will be measured by how many medication injections you receive and how often opioid relapse (using opioids again) occurs over 26 weeks. You may be able to join if you are 18-28 years old, have an OUD diagnosis, plan to receive treatment with XR-NTX or XR-BUP, and are willing to have a family member or other important person involved in your treatment. The current recruitment status is unclear.

Study design

This is an interventional study with a planned enrollment of 150 participants. The study aims to refine the YORS intervention through stakeholder input and pilot iterative testing followed by an efficacy randomized controlled trial.

What's involved

You would receive injections of MOUD (Medication for Opioid Use Disorder) like XR-NTX or XR-BUP. Data on opioid relapse will be collected every two weeks for 26 weeks.

Compensation

Not stated in the trial record.

Follow-up

Your progress will be monitored for 26 weeks, with data collected every two weeks during that period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.